Zacks: Analysts Anticipate Acadia Healthcare Company Inc (NASDAQ:ACHC) to Announce $0.54 Earnings Per Share

Equities research analysts expect Acadia Healthcare Company Inc (NASDAQ:ACHC) to post earnings per share of $0.54 for the current quarter, according to Zacks. Seven analysts have issued estimates for Acadia Healthcare’s earnings, with the highest EPS estimate coming in at $0.58 and the lowest estimate coming in at $0.47. Acadia Healthcare posted earnings of $0.55 per share in the same quarter last year, which indicates a negative year-over-year growth rate of 1.8%. The firm is expected to issue its next quarterly earnings results on Monday, November 4th.

According to Zacks, analysts expect that Acadia Healthcare will report full year earnings of $2.14 per share for the current year, with EPS estimates ranging from $2.02 to $2.23. For the next year, analysts expect that the business will post earnings of $2.44 per share, with EPS estimates ranging from $2.03 to $2.97. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research analysts that cover Acadia Healthcare.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Tuesday, July 30th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.59 by $0.02. The business had revenue of $789.00 million during the quarter, compared to analyst estimates of $795.31 million. Acadia Healthcare had a positive return on equity of 7.20% and a negative net margin of 6.80%. Acadia Healthcare’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.70 earnings per share.

ACHC has been the subject of several research reports. Zacks Investment Research lowered Acadia Healthcare from a “hold” rating to a “sell” rating and set a $31.00 target price for the company. in a research note on Wednesday, August 7th. BMO Capital Markets lifted their target price on Acadia Healthcare from $33.00 to $36.00 and gave the company a “market perform” rating in a report on Wednesday, May 1st. Mizuho set a $30.00 target price on Acadia Healthcare and gave the company a “hold” rating in a report on Friday, May 31st. ValuEngine upgraded Acadia Healthcare from a “strong sell” rating to a “sell” rating in a report on Wednesday, April 24th. Finally, BidaskClub lowered Acadia Healthcare from a “sell” rating to a “strong sell” rating in a report on Tuesday, August 6th. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $37.00.

A number of large investors have recently added to or reduced their stakes in the stock. Royal Bank of Canada increased its position in Acadia Healthcare by 3.1% during the 2nd quarter. Royal Bank of Canada now owns 390,923 shares of the company’s stock worth $13,661,000 after purchasing an additional 11,914 shares during the period. Concourse Capital Management LLC increased its position in Acadia Healthcare by 9.3% during the 2nd quarter. Concourse Capital Management LLC now owns 132,570 shares of the company’s stock worth $4,633,000 after purchasing an additional 11,250 shares during the period. Eaton Vance Management increased its position in Acadia Healthcare by 58.6% during the 2nd quarter. Eaton Vance Management now owns 108,311 shares of the company’s stock worth $3,785,000 after purchasing an additional 40,000 shares during the period. Nuveen Asset Management LLC acquired a new position in Acadia Healthcare during the 2nd quarter worth approximately $8,508,000. Finally, UBS Asset Management Americas Inc. increased its position in Acadia Healthcare by 0.6% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 103,625 shares of the company’s stock worth $3,622,000 after purchasing an additional 572 shares during the period.

ACHC traded up $0.08 during midday trading on Friday, hitting $27.41. The stock had a trading volume of 8,655 shares, compared to its average volume of 788,749. The company has a market cap of $2.43 billion, a P/E ratio of 12.20, a price-to-earnings-growth ratio of 1.21 and a beta of 0.68. The business has a fifty day moving average of $31.10 and a 200 day moving average of $31.00. The company has a debt-to-equity ratio of 1.53, a quick ratio of 1.09 and a current ratio of 1.09. Acadia Healthcare has a 1 year low of $24.27 and a 1 year high of $45.35.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.

Read More: What is a Stop Order?

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.